Gastrointestinal Drugs Market 2017 Research In-Depth Analysis, Applications, Forecasts To 2023
The latest report on Gastrointestinal Drugs
Market by Infinium global research gives complete coverage of the
Gastrointestinal Drugs Market by drug category(acid neutralizers, antidiarrheal
& laxatives, anti-inflammatory), route of administration(oral, parenteral,
rectal), disease type(gastro-esophageal reflux disorder, inflammatory bowel
disease), end user(hospital pharmacies, retail pharmacies) in terms of key
trends, market size, forecast and CAGR growth over the period of 2017 to 2023.
In addition, the study covers deep dive into key product and applications
trends in the regional markets of Gastrointestinal Drugs such as North America,
Europe, Asia-Pacific and Latin America over the short run and long run.
The report on global
Gastrointestinal Drugs Market provides qualitative and quantitative analysis
for the period of 2017 to 2023. According to the report the global
Gastrointestinal Drugs Market value is projected to reach USD 59.83 billion by
2023, growing with a CAGR of 4.5 % to 5.0% from 2017 to 2023. The global Gastrointestinal
Drugs Market size was totaled 46.5 Billion in 2016.
Market Insights
Global gastrointestinal drugs market experienced progressive growth over
the past few years. As per the report published by world gastrointestinal
organization in 2015, almost 35%-40% of world’s population is suffering from
acute and chronic gastrointestinal complications. This includes
gastrointestinal disease and disorder, due to change and dietary pattern, which
is predominantly responsible for global growth of this market. Moreover, rising
prevalence of gastrointestinal disease across the globe is equally drives
global growth. Increasing investment in research and development activities in
older to develop new drugs along with growing awareness pertaining to
availability of these treatments have raised considerable demand for GI drugs.
Apart from this, technological reforms in the treatment offers superior outputs
and expected to contribute significantly in the forthcoming years. The exact
cause of GI related disorders are still unknown, due to which cure for these
disorders is not available. This may hamper global growth of gastrointestinal
drugs market by inviting various complications.
Segments Covered:
The report segments the
global Gastrointestinal Drugs market by drug category, by route of
administration, by disease type, by end user and by region. The market size of
each segment has been provided in terms of value (USD). Market segmentation
based on type of drugs category includes Acid Neutralizers, Antidiarrheal and
Laxatives, antiemetic, Anti-inflammatory, and others. Wherein acid neutralizers
further sub segmented into antacids, H2 antagonists, and Proton Pump Inhibitor.
On the basis of route of administration global market has been segmented into
oral, parenteral, and rectal. Moreover, Market based on disease type includes
gastro-esophageal reflux disorder (GERD), Inflammatory bowel disease, and
other, whereas, end user segment comprises hospital pharmacies, retail
pharmacies and other.
Company Profiles
- Abbott Laboratories
- Allergan Plc
- AstraZeneca
- Bayer AG
- BoehringerIngelheim GmbH
- GlaxoSmithKline Plc.
- Janssen Biotech Inc.
- Sanofi
- Takeda Pharmaceutical
- Valeant Pharmaceuticals Inc.
Key topics covered:
1. Preface
2. Executive
Summary
3. Global
Gastrointestinal Drugs Market Overview
4. Global
Gastrointestinal Drugs Market : IGR Snapshots
5. Global
Gastrointestinal Drugs by Drug Category (USD Billion) 2017 – 2023
6. Global
Gastrointestinal Drugs Market Analysis, by Route Of Administration (USD
Billion) 2017 – 2023
7. Global
Gastrointestinal Drugs Market Analysis, by Disease Type (USD Billion) 2017 –
2023
8. Global
Gastrointestinal Drugs Market Analysis, by End User (USD Billion) 2017 – 2023
9. Global
Gastrointestinal Drugs Market Analysis, by Region (USD Billion) 2017 – 2023
10. Company Profiles
Click to View Complete Report @https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_gastrointestinal_drugs_market
Comments
Post a Comment